CortexBio® Uniting Rare Diseases and the Science of Ageing
ThesisResearchServicesFounderContact Work with us
Work with us

The thesis, in plain English

Ageing as a Fatal Inborn Error of Metabolism

A simplified summary of the CortexBio white paper

What This White Paper Is About

Imagine if ageing wasn't just something that "happens" to us, but rather a condition that we are all born with — like a very slow metabolic disorder that affects everyone. That's the revolutionary idea this white paper explores.

The big idea in simple terms

Traditional view of ageing

Most people think ageing happens because:

  • Our bodies wear out over time
  • Environmental damage accumulates
  • It's just “natural” and inevitable

The new perspective

Research suggests ageing is actually:

  • A metabolic condition we're born with
  • Similar to rare genetic disorders, but universal
  • Potentially treatable, not inevitable
Traditional Inevitable wearEnvironmental damageNatural process
Shared features Enzyme declineEnergy crisisMetabolite imbalance
New view Treatable conditionBorn with itTargetable pathways
Key finding 275 metabolic disorders are treatable today — the same approaches might work for ageing.
The big idea: ageing shares the structure of a treatable metabolic disorder — it just affects everyone.

Key Concepts

What are metabolic disorders?

Think of your body as a complex factory: enzymes are the workers that process materials, metabolites are the materials being processed, and energy is what keeps everything running. In metabolic disorders, some workers (enzymes) don't function properly, causing materials to pile up or run out.

How is ageing similar?

  • Our metabolic "workers" slow down
  • Materials get processed incorrectly
  • Energy production decreases
  • Waste products accumulate

The Evidence

1. Enzyme decline

Just like a factory with ageing equipment: key enzymes lose 20–50% of their activity by age 80, affecting how our bodies process nutrients and create energy.

2. Energy crisis

Like a phone with a degrading battery: our cells produce less energy as we age. This affects every organ, especially high-energy ones like the brain and heart.

3. Waste accumulation

Similar to a city with a failing waste management system: toxic byproducts build up in our cells, causing inflammation and damage.

Why This Matters

For medicine

We already treat 275 metabolic disorders successfully. These same approaches might work for ageing, and early detection could lead to prevention.

For you

Ageing might not be as inevitable as we thought: future treatments could extend healthy years, and understanding ageing differently opens new possibilities.

The ageing paradigm shift

Old thinking New thinking
Goal
Comfort care
Extend years
Focus
Manage symptoms
Target causes
Action
Nothing done
Can measure
Perspective
Inevitable
Treatable
OldDeclineNeutralProgressNew

Approach scale

The paradigm shift: from managing decline to targeting causes.

What's Being Done

Current research

  • Testing drugs that work for metabolic disorders in ageing
  • Developing ways to measure "metabolic age"
  • Creating personalised treatment approaches

Promising treatments

  • Senolytics — drugs that remove damaged cells
  • NAD+ boosters — supplements that restore cellular energy
  • Metabolic modulators — medications that optimise the metabolism

The Bottom Line

This research suggests that ageing is a metabolic process we're all born with; it shares features with treatable genetic disorders; new treatments based on this understanding are in development; and the goal is not just living longer, but staying healthier longer.

What Can We Do Now

While research continues, evidence suggests these help:

  • Regular exercise (especially strength training)
  • Balanced nutrition
  • Good sleep habits
  • Stress management
  • Regular health check-ups

Looking Forward

This new understanding of ageing opens doors to treatments that address root causes, not just symptoms; personalised approaches based on individual metabolism; and a future where ageing is manageable, not inevitable.

This simplified summary is based on the scientific white paper “Ageing as a Fatal Inborn Error of Metabolism” by CortexBio. The argument is made in full in our published research, or contact us at info@cortexbio.co.uk.

CortexBio®
ThesisResearchCircadian clockServicesFounder InsightsContactTermsLinkedIn
Uniting Rare Diseases and the Science of Ageing
CortexBio® is a registered trade mark of CortexBio Limited (UK00004354495)